Subsequent Events	12 Months Ended
Jun. 30, 2013
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14. SUBSEQUENT EVENTS On August 29, 2013, the Company issued senior secured convertible notes (the “August Convertible Notes”) with an original issue discount of 12% and a conversion price of $0.068 per share (the “August Conversion Price”) for gross proceeds of $616,000. The term of the August Convertible Notes include an eighteen-month maturity period, with partial redemption beginning on September 1, 2014. The August Convertible Notes bear an annual interest rate of 8%, which is paid quarterly in the form of cash or equity. Interest is payable in cash or at the Company’s option in shares of common stock, provided certain conditions are met, based on a share value equal to the lesser of (a) 90% of the average of the volume weighted average price (the “VWAP”) for the 20 consecutive trading days prior to the applicable interest payment date and (b) 100% of the average of the VWAP for the 20 consecutive trading days prior to the applicable interest payment date less $0.01. In connection with the financing described above, the Company entered into Amendment and Waiver Agreements (collectively, the “Amendment Agreements”) with the holders (collectively, the “Holders”) of substantially all of the securities issued in connection with the Company’s Bridge Notes, PPO, short-term loans and PPO and Bridge Broker Warrants (collectively, the Transactions”) pursuant to which the Company reduced the exercise prices of all of its outstanding Series A, Series B, Series C, Series D and Series E common stock purchase warrants (collectively, the “Warrants”) as follows: the exercise price per share of the Series A Warrants that had an initial exercise price of $0.25 was reduced to $.01; the exercise price per share of the Series B Warrants that had an initial exercise price of $0.50 was reduced to $.015; the exercise price per share of the Series C Warrants that had an initial exercise price of $1.00 was reduced to $0.03; and the exercise price per share of the Series D and Series E Warrants that had an initial exercise price of $0.25 was reduced to $0.01. In consideration of the exercise price reductions, the Holders of substantially all of the securities agreed to permanently waive all past and future exercise price and share number anti-dilution adjustment provisions that would otherwise be triggered by share issuances by the Company at prices less than the purchase, exercise or conversion price of any securities acquired by the holders in the Transactions or underlying any of such securities. The Amendment Agreements also provided for a waiver of all penalties incurred by the Company under the terms of the PPO registration rights agreement as a result of the Company’s failure to timely file and effect the registration for resale of the private placement securities.

On August 29, 2013, the Company issued senior secured convertible notes (the “August Convertible Notes”) with an original issue discount of 12% and a conversion price of $0.068 per share (the “August Conversion Price”) for gross proceeds of $616,000. The term of the August Convertible Notes include an eighteen-month maturity period, with partial redemption beginning on September 1, 2014. The August Convertible Notes bear an annual interest rate of 8%, which is paid quarterly in the form of cash or equity. Interest is payable in cash or at the Company’s option in shares of common stock, provided certain conditions are met, based on a share value equal to the lesser of (a) 90% of the average of the volume weighted average price (the “VWAP”) for the 20 consecutive trading days prior to the applicable interest payment date and (b) 100% of the average of the VWAP for the 20 consecutive trading days prior to the applicable interest payment date less $0.01.

In connection with the financing described above, the Company entered into Amendment and Waiver Agreements (collectively, the “Amendment Agreements”) with the holders (collectively, the “Holders”) of substantially all of the securities issued in connection with the Company’s Bridge Notes, PPO, short-term loans and PPO and Bridge Broker Warrants (collectively, the Transactions”) pursuant to which the Company reduced the exercise prices of all of its outstanding Series A, Series B, Series C, Series D and Series E common stock purchase warrants (collectively, the “Warrants”) as follows: the exercise price per share of the Series A Warrants that had an initial exercise price of $0.25 was reduced to $.01; the exercise price per share of the Series B Warrants that had an initial exercise price of $0.50 was reduced to $.015; the exercise price per share of the Series C Warrants that had an initial exercise price of $1.00 was reduced to $0.03; and the exercise price per share of the Series D and Series E Warrants that had an initial exercise price of $0.25 was reduced to $0.01.

In consideration of the exercise price reductions, the Holders of substantially all of the securities agreed to permanently waive all past and future exercise price and share number anti-dilution adjustment provisions that would otherwise be triggered by share issuances by the Company at prices less than the purchase, exercise or conversion price of any securities acquired by the holders in the Transactions or underlying any of such securities. The Amendment Agreements also provided for a waiver of all penalties incurred by the Company under the terms of the PPO registration rights agreement as a result of the Company’s failure to timely file and effect the registration for resale of the private placement securities.